AKBETA Drug Patent Profile
✉ Email this page to a colleague
When do Akbeta patents expire, and when can generic versions of Akbeta launch?
Akbeta is a drug marketed by Epic Pharma Llc and is included in two NDAs.
The generic ingredient in AKBETA is levobunolol hydrochloride. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the levobunolol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Akbeta
A generic version of AKBETA was approved as levobunolol hydrochloride by BAUSCH AND LOMB on March 4th, 1994.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AKBETA?
- What are the global sales for AKBETA?
- What is Average Wholesale Price for AKBETA?
Summary for AKBETA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 35 |
| Patent Applications: | 563 |
| DailyMed Link: | AKBETA at DailyMed |
US Patents and Regulatory Information for AKBETA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epic Pharma Llc | AKBETA | levobunolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 074779-001 | Oct 29, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Epic Pharma Llc | AKBETA | levobunolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 074780-001 | Oct 29, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
